To do or not to do living donor hepatectomy in Jehovah's Witnesses: single institution experience of the first 13 resections.
Living donor liver transplantation has come to be an acceptable alternative to deceased donor transplants. Several ethical issues related to living donation have been raised in the face of reported perioperative morbidity and mortality. We report our experience in 13 consecutive Jehovah's Witness (JW) donor hepatectomies. From June 1999 to April 2004, 13 adult JW donors underwent donor hepatectomies at the USC-University Hospital. Nine donors underwent right lobectomy with a 62% mean volume of the liver resected. Four donors underwent a left lateral segmentectomy with a mean volume of 17.8%. Cell scavenging techniques, acute normovolemic hemodilution and fractionated products were used. The mean hospital stay was 6.2 days. All donors are alive and well at a median follow-up time of 3 years and 4 months. Live liver donation can be done safely in JW population if performed within a comprehensive bloodless surgery program.
Jabbour
Nicolas
N
The Division of Hepatobiliary/Pancreatic Surgery and Transplant Surgery, University of Southern California, University Hospital, Los Angeles, California, USA. njabbour@surgery.usc.edu
Gagandeep
Singh
S
Bramstedt
Katrina A
KA
Brenner
Megan
M
Mateo
Rodrigo
R
Selby
Rick
R
Genyk
Yuri
Y
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion / Q000592:standards*; D005260:Female; D006085:Graft Survival; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D033221:Jehovah's Witnesses; D008099:Liver / Q000473:pathology; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D012068:Religion and Medicine; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome